References
- Stewart J, Manmathan G, Wilkinson P. Primary prevention of cardiovascular disease: A review of contemporary guidance and literature. JRSM Cardiovasc Dis. 2017;6:2048004016687211.
- Kargozar S, Hamzehlou S, Baino F. Potential of bioactive glasses for cardiac and pulmonary tissue engineering. Materials. 2017;10(12):1429.
- Boroumand S, Asadpour S, Akbarzadeh A, et al. Heart valve tissue engineering: an overview of heart valve decellularization processes. Regen Med. 2018;13(1):41–54.
- Asadpour S, Yeganeh H, Ai J, et al. A novel polyurethane modified with biomacromolecules for small-diameter vascular graft applications. J Mater Sci. 2018;53(14):9913–9927.
- Bertero A, Murry CE. Hallmarks of cardiac regeneration. Nat Rev Cardiol. 2018;15(10):579–580.
- Gera M, Sharma N, Ghosh M, et al. Nanoformulations of curcumin: an emerging paradigm for improved remedial application. Oncotarget. 2017;8(39):66680.
- Reis LA, Chiu LL, Feric N, et al. Biomaterials in myocardial tissue engineering. J Tissue Eng Regen Med. 2016;10(1):11–28.
- Alcon A, Cagavi Bozkulak E, Qyang Y. Regenerating functional heart tissue for myocardial repair. Cell Mol Life Sci. 2012;69(16):2635–2656.
- Asadpour S, Yeganeh H, Ai J, et al. Polyurethane-polycaprolactone blend patches: scaffold characterization and cardiomyoblast adhesion, proliferation, and function. ACS Biomater Sci Eng. 2018;4(12):4299–4310.
- Ahangari N, Kargozar S, Ghayour‐Mobarhan M, et al. Curcumin in tissue engineering: A traditional remedy for modern medicine. BioFactors. 2019;45(2):135–151.
- Shakeri A, Ward N, Panahi Y, et al. Anti-angiogenic activity of curcumin in cancer therapy: a narrative review. Curr Vasc Pharmacol. 2019;17(3):262–269.
- Montalbán M, Coburn J, Lozano-Pérez A, et al. Production of curcumin-loaded silk fibroin nanoparticles for cancer therapy. Nanomaterials. 2018;8(2):126.
- Kumar SU, Kumar V, Priyadarshi R, et al. pH-responsive prodrug nanoparticles based on xylan-curcumin conjugate for the efficient delivery of curcumin in cancer therapy. Carbohydr Polym. 2018;188:252–259.
- Kasi PD, Tamilselvam R, Skalicka-Woźniak K, et al. Molecular targets of curcumin for cancer therapy: an updated review. Tumor Biol. 2016;37(10):13017–13028.
- Wei Y, Pu X, Zhao L. Preclinical studies for the combination of paclitaxel and curcumin in cancer therapy. Oncol Rep. 2017;37(6):3159–3166.
- Zhang Y, Yang C, Wang W, et al. Co-delivery of doxorubicin and curcumin by pH-sensitive prodrug nanoparticle for combination therapy of cancer. Sci Rep. 2016;6:21225.
- Danafar H, Davaran S, Rostamizadeh K, et al. Biodegradable m-PEG/PCL core-shell micelles: preparation and characterization as a sustained release formulation for curcumin. Adv Pharm Bull. 2014;4(Suppl 2):501–510.
- Kheiri Manjili H, Ghasemi P, Malvandi H, et al. Pharmacokinetics and in vivo delivery of curcumin by copolymeric mPEG-PCL micelles. Eur J Pharm Biopharm. 2017;116:17–30.
- Perrone D, Ardito F, Giannatempo G, et al. Biological and therapeutic activities, and anticancer properties of curcumin. Exp Ther Med. 2015;10(5):1615–1623.
- Uğuz AC, Öz A, Nazıroğlu M. Curcumin inhibits apoptosis by regulating intracellular calcium release, reactive oxygen species and mitochondrial depolarization levels in SH-SY5Y neuronal cells. J Recept Signal Transduct. 2016;36(4):395–401.
- Wang J, Wang H, Zhu R, et al. Anti-inflammatory activity of curcumin-loaded solid lipid nanoparticles in IL-1β transgenic mice subjected to the lipopolysaccharide-induced sepsis. Biomaterials. 2015;53:475–483.
- Lundvig DM, Pennings SW, Brouwer KM, et al. Curcumin induces differential expression of cytoprotective enzymes but similar apoptotic responses in fibroblasts and myofibroblasts. Exp Cell Res. 2015;330(2):429–441.
- Levraut J, Iwase H, Shao Z-H, et al. Cell death during ischemia: relationship to mitochondrial depolarization and ROS generation. Am J Physiol Heart Circ Physiol. 2003;284(2):H549–H558.
- Panth N, Paudel KR, Parajuli K. Reactive oxygen species: a key Hallmark of cardiovascular disease. Adv Med. 2016;12:2016.
- Liu H, Wang C, Qiao Z, et al. Protective effect of curcumin against myocardium injury in ischemia reperfusion rats. Pharm Biol. 2017;55(1):1144–1148.
- Cohn JN. Structural basis for heart failure: ventricular remodeling and its pharmacological inhibition. Circulation. 1995;91(10):2504–2507.
- Wang R, Zhang J, Zhang M, et al. Curcumin attenuates IR-induced myocardial injury by activating SIRT3. Eur Rev Med Pharmacol Sci. 2018;22:1150–1160.
- Frangogiannis NG. The inflammatory response in myocardial injury, repair, and remodelling. Nat Rev Cardiol. 2014;11(5):255–265.
- Lv FH, Yin HL, He YQ, et al. Effects of curcumin on the apoptosis of cardiomyocytes and the expression of NF-κB, PPAR-γ and Bcl-2 in rats with myocardial infarction injury. Exp Ther Med. 2016;12(6):3877–3884.
- Chang N-S, Joki N, Mattison J, et al. Characterization of serum adhesive proteins that block tumor necrosis factor-mediated cell death. Cell Death Differ. 1997;4(8):779.
- Gupta SC, Tyagi AK, Deshmukh-Taskar P, et al. Downregulation of tumor necrosis factor and other proinflammatory biomarkers by polyphenols. Arch Biochem Biophys. 2014;559:91–99.
- Mahmoudi M, Zhao M, Matsuura Y, et al. Infection-resistant MRI-visible scaffolds for tissue engineering applications. Bioimpacts. 2016;6(2):111.
- Zorofchian Moghadamtousi S, Abdul Kadir H, Hassandarvish P, et al. A review on antibacterial, antiviral, and antifungal activity of curcumin. Biomed Res Int. 2014;12:2014.
- Rai D, Singh JK, Roy N, et al. Curcumin inhibits FtsZ assembly: an attractive mechanism for its antibacterial activity. Biochem J. 2008;410(1):147–155.
- Han S, Yang Y. Antimicrobial activity of wool fabric treated with curcumin. Dyes Pigm. 2005;64(2):157–161.
- Tesaki S, Tanabe S, Ono H, et al. 4-Hydroxy-3-nitrophenylacetic and sinapic acids as antibacterial compounds from mustard seeds. Biosci Biotechnol Biochem. 1998;62(5):998–1000.
- Gunes H, Gulen D, Mutlu R, et al. Antibacterial effects of curcumin: an in vitro minimum inhibitory concentration study. Toxicol Ind Health. 2016;32(2):246–250.
- Chen H, Yang X, Lu K, et al. Inhibition of high glucose-induced inflammation and fibrosis by a novel curcumin derivative prevents renal and heart injury in diabetic mice. Toxicol Lett. 2017;278:48–58.
- Xiao J, Sheng X, Zhang X, et al. Curcumin protects against myocardial infarction-induced cardiac fibrosis via SIRT1 activation in vivo and in vitro. Drug Des Devel Ther. 2016;10:1267–1277.
- Yeh C-H, Lin Y-M, Wu Y-C, et al. Inhibition of NF-κB activation can attenuate ischemia/reperfusion-induced contractility impairment via decreasing cardiomyocytic proinflammatory gene up-regulation and matrix metalloproteinase expression. J Cardiovasc Pharmacol. 2005;45(4):301–309.
- Aggarwal BB, Harikumar KB. Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseases. Int J Biochem Cell Biol. 2009;41(1):40–59.
- Srivastava G, Mehta JL. Currying the heart: curcumin and cardioprotection. J Cardiovasc Pharmacol Ther. 2009;14(1):22–27.
- Hjorth Tønnesen H. Solubility and stability of curcumin in solutions containing alginate and other viscosity modifying macromolecules-Studies of curcumin and curcuminoids. Die Pharmazie- Int J Pharm Sci. 2006;61(8):696–700.
- Sarika P, James NR. Polyelectrolyte complex nanoparticles from cationised gelatin and sodium alginate for curcumin delivery. Carbohydr Polym. 2016;148:354–361.
- Balaji S, Chempakam B. Toxicity prediction of compounds from turmeric (Curcuma longa L). Food Chem Toxicol. 2010;48(10):2951–2959.
- Ting C-Y, Wang H-E, Yu C-C, et al. Curcumin triggers DNA damage and inhibits expression of DNA repair proteins in human lung cancer cells. Anticancer Res. 2015;35(7):3867–3873.
- Mancuso C, Barone E. Curcumin in clinical practice: myth or reality? Trends Pharmacol Sci. 2009;30(7):333–334.
- Chen Q-Z, Harding SE, Ali NN, et al. Biomaterials in cardiac tissue engineering: ten years of research survey. Mater Sci Eng R Rep. 2008;59(1–6):1–37.
- Danafar H. Study of the composition of polycaprolactone/poly (ethylene glycol)/polycaprolactone copolymer and drug-to-polymer ratio on drug loading efficiency of curcumin to nanoparticles. Jundishapur J Nat Pharm Prod. 2017;12:1.
- Tallawi M, Rosellini E, Barbani N, et al. Strategies for the chemical and biological functionalization of scaffolds for cardiac tissue engineering: a review. J Royal Soc Interface. 2015;12(108):20150254.
- El Khoury ED, Patra D. Ionic liquid expedites partition of curcumin into solid gel phase but discourages partition into liquid crystalline phase of 1, 2-dimyristoyl-sn-glycero-3-phosphocholine liposomes. J Phys Chem A. 2013;117(33):9699–9708.
- Moussa Z, Chebl M, Patra D. Fluorescence of tautomeric forms of curcumin in different pH and biosurfactant rhamnolipids systems: application towards on-off ratiometric fluorescence temperature sensing. J Photochem Photobiol B Biol. 2017;173:307–317.
- Danafar H. Applications of copolymeric nanoparticles in drug delivery systems. Drug Res (Stuttg). 2016;66(10):506–519.
- Mirzaie Z, Ansari M, Kordestani SS, et al. Preparation and characterization of curcumin‐loaded polymeric nanomicelles to interference with amyloidogenesis through glycation method. Biotechnol Appl Biochem. 2019.
- El-Sherbiny IM, Yacoub MH. Hydrogel scaffolds for tissue engineering: progress and challenges. Glob Cardiol Sci Pract. 2013;38:316–342.
- Soppimath KS, Aminabhavi TM, Dave AM, et al. Stimulus-responsive“smart” hydrogels as novel drug delivery systems. Drug Dev Ind Pharm. 2002;28(8):957–974.
- Zhang D, Xu Q, Wang N, et al. A complex micellar system co-delivering curcumin with doxorubicin against cardiotoxicity and tumor growth. Int J Nanomedicine. 2018;13:4549.
- Liu H, Xu H, Jiang Y, et al. Preparation, characterization, in vivo pharmacokinetics, and biodistribution of polymeric micellar dimethoxycurcumin for tumor targeting. Int J Nanomedicine. 2015;10:6395.
- Tønnesen HH, Másson M, Loftsson T. Studies of curcumin and curcuminoids. XXVII. Cyclodextrin complexation: solubility, chemical and photochemical stability. Int J Pharm. 2002;244(1–2):127–135.
- Lin -C-C, Lin H-Y, Chen H-C, et al. Stability and characterisation of phospholipid-based curcumin-encapsulated microemulsions. Food Chem. 2009;116(4):923–928.
- Anitha A, Maya S, Deepa N, et al. Efficient water soluble O-carboxymethyl chitosan nanocarrier for the delivery of curcumin to cancer cells. Carbohydr Polym. 2011;83(2):452–461.
- Anitha A, Deepagan V, Rani VD, et al. Preparation, characterization, in vitro drug release and biological studies of curcumin loaded dextran sulphate–chitosan nanoparticles. Carbohydr Polym. 2011;84(3):1158–1164.
- Wu C, Chang J. Multifunctional mesoporous bioactive glasses for effective delivery of therapeutic ions and drug/growth factors. J Control Release. 2014;193:282–295.
- Kargozar S, Montazerian M, Hamzehlou S, et al. Mesoporous bioactive glasses: promising platforms for antibacterial strategies. Acta Biomater. 2018;81:1–19.
- Kargozar S, Mozafari M, Hamzehlou S, et al. Mesoporous bioactive glasses (MBGs) in cancer therapy: full of hope and promise. Mater Lett. 2019;251:241–246.
- Kargozar S, Hamzehlou S, Baino F. Can bioactive glasses be useful to accelerate the healing of epithelial tissues? Mater Sci Eng C. 2019;97:1009–1020.
- Shruti S, Salinas AJ, Ferrari E, et al. Curcumin release from cerium, gallium and zinc containing mesoporous bioactive glasses. Microporous Mesoporous Mater. 2013;180:92–101.